Business ❯ Pharmaceutical Industry ❯ Pricing Strategies ❯ Market Competition

Eli Lilly

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Access will remain limited without lower prices and more production, the WHO warns.

Eli Lilly to Raise UK Mounjaro Prices by Up to 170% in September